| Acquired aplastic anemia patients using single agent cyclosporine A, in resource poor setting L Seraj, A Cili, A Perolla, P Pulluqi, E Çalliku, T Caja, A Ivanaj Blood 138, 4312, 2021 | 2 | 2021 |
| The diagnostic value of flow cytometry imunophenotyping in an Albanian patient population with a preliminary clinical diagnosis of chronic lymphocytic leukemia. V Semanaj, A Pecani, T Dedej, A Barbullushi, Z Ylli, T Curaj, P Pulluqi, ... | 2 | 2014 |
| Aplastic Anaemia in Pregnancy: A Case-Based Comprehensive Review of the Literature A Perolla, B Cela, V Semanaj, T Dedej-Kurti, T Caja Cureus 16 (4), 2024 | 1 | 2024 |
| Uncovering the Challenges of Rare Diseases: Insights From a Retrospective Cross-Sectional Study in Albania (2005-2022) A Perolla, E Çalliku, A Cili, T Caja, P Pulluqi, A Ivanaj Cureus 16 (1), 2024 | 1 | 2024 |
| UNRAVELING THE GUARDIAN OF THE GENOME: THE ROLE OF P53 IN CHRONIC LYMPHOCYTIC LEUKEMIA E Calliku, A Cili, A Perolla, T Caja, P Pulluqi, A Ivanaj, M Tereza Albanian, 59, 2024 | | 2024 |
| The Importance of Comorbidities in the Life Expectancy of Patients with Myelodysplastic Syndromes.-Realword data from Albania A Perolla, I Akshija, T Caja International Journal of BioLife Sciences (IJBLS) 3 (2), 103-104, 2024 | | 2024 |
| Improving Hemophilia Care in Low-and Middle-Income Countries: Addressing Challenges and Enhancing Quality of Life A Perolla, B Kalaja Cureus 16 (6), 2024 | | 2024 |
| Real world data on hereditary spherocytosis in Albania–retrospective case-control study (2005-2015) A Barbullushi-Ruçaj, A Perolla, T Dedej-Kurti, E Çalliku, E Petrela Clinica Chimica Acta 558, 118404, 2024 | | 2024 |
| Evaluating secondary acute myeloid leukemia (T-AML) post-breast cancer therapy: Case series from Albania E Çalliku, A Barbullushi-Ruçaj, T Dedej-Kurti, E Lamaj, V Semanaj, ... Clinica Chimica Acta 558, 118381, 2024 | | 2024 |
| CD47 in Myelodysplastic Syndromes: A Deep Dive into Its Role and Therapeutic Implications A Perolla International Journal of BioLife Sciences (IJBLS) 2 (2), 291-294, 2023 | | 2023 |
| PB2068: RARITY MATTERS! THE EXPERIENCE IN OUR ADULT HEMATOLOGY SERVICE. A Perolla, A Cili, E Çalliku, T Caja, P Pulluqi, A Fico, A Ivanaj HemaSphere 7 (S3), e607897b, 2023 | | 2023 |
| PB2658: IMMUNE THROMBOCYTOPENIC PURPURA IN ALBANIA S Grazhdani, A Cili, A Shpuza, A Perolla, E Calliku, P Pulluqi, T Caja, ... HemaSphere 7 (S3), e399380e, 2023 | | 2023 |
| PB2236: POPULATION BASED INCIDENCE OF ESSENTIAL THROMBOCYTHEMIA: AN ALBANIAN STUDY (2007-2021) A Perolla, E Çalliku, A Cili, T Caja, P Pulluqi, A Ivanaj HemaSphere 7 (S3), e9646322, 2023 | | 2023 |
| Aplastic Anemia in Pregnancy: A Case-Based Comprehensive Review of the Literature A Perolla International Journal of BioLife Sciences (IJBLS) 2 (1), 9-17, 2023 | | 2023 |
| Clozapine related risk of lymphoid malignancies in Treatment-Resistant Schizophrenia–A case report and review of the literature A Perolla Journal of Biological Studies 6 (1), 1-6, 2023 | | 2023 |
| PB2057: REAL-WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB–A 6 YEAR ANALYSIS IN ALBANIAN POPULATION A Perolla, P Pulluqi, A Cili, E Calliku, T Caja, A Ivanaj HemaSphere 6, 1928-1929, 2022 | | 2022 |
| PB2214: SCD POPULATION SURVEY IN ALBANIA, A PROSPECTIVE NON-INTERVENTIONAL MULTI-CENTER STUDY EVALUATING DISEASE AND PATIENTS CHARACTERISTICS OF SICKLE CELL DISEASE IN ALBANIAN … A Cili, E Petrela, A Zaka, A Hatellari, P Pulluqi, T Caja, A Perolla, E Calliku, ... HemaSphere 6, 2084-2085, 2022 | | 2022 |
| PB1879: OVERALL SURVIVAL OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB IN ALBANIA (2018-2022) E Calliku, A Perolla, A Cili, P Pulluqi, T Caja, A Ivanaj HemaSphere 6, 1759-1760, 2022 | | 2022 |
| COLON RESTORATION AND REMOVAL OF STOMA IN PATIENT WITH CONGENITAL FACTOR X (TEN) DEFICIENCY B Kalaja, A Perolla, M Xhafa HAEMOPHILIA 27, 151-152, 2021 | | 2021 |
| PB2089 THE GENETIC PROFILE OF THE PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROMES IN ALBANIA (2009-2013) A Perolla, E Çalliku, A Cili, P Pulluqi, T Nakuci, A Ivanaj, A Pushi HemaSphere 3 (S1), 941, 2019 | | 2019 |
